Evidence map›Paper›PMID 35045282›Full record

ArticleCell reports2022

The portrait of liver cancer is shaped by mitochondrial genetics.

Mrittika Chattopadhyay, Edmund Charles Jenkins, Ana Victoria Lechuga-Vieco, Kai Nie, Maria Isabel Fiel, Alexander Rialdi, Ernesto Guccione, Jose Antonio Enriquez, Daniela Sia, Amaia Lujambio and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. [Research progress on the mechanism of action of mitophagy in the occurrence and development of liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mrittika ChattopadhyayIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Medicine, Division of Hematology/Oncology, New York, NY 10029, USA.
Edmund Charles JenkinsIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Medicine, Division of Hematology/Oncology, New York, NY 10029, USA.
Ana Victoria Lechuga-ViecoCentro Nacional de Investigaciones Cardiovasculares Carlos III, CIBERFES, Madrid 28029, Spain.
Kai NieIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Oncological Sciences, New York, NY 10029, USA.
Maria Isabel FielIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Pathology, New York, NY 10029, USA.
Alexander RialdiIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Oncological Sciences, New York, NY 10029, USA.
Ernesto GuccioneIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Oncological Sciences, New York, NY 10029, USA.
Jose Antonio EnriquezCentro Nacional de Investigaciones Cardiovasculares Carlos III, CIBERFES, Madrid 28029, Spain.
Daniela SiaIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Medicine, Division of Liver Diseases, New York, NY 10029, USA.
Amaia LujambioIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Oncological Sciences, New York, NY 10029, USA.
Doris GermainIcahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Department of Medicine, Division of Hematology/Oncology, New York, NY 10029, USA. Electronic address: doris.germain@mssm.edu.
Tisch Cancer InstituteSpanish National Centre for Cardiovascular Research · ESTisch Hospital · US

Funding

Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity.R01AG059635 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GERMAIN, DORIS A · 2018 to 2022
$2.2M
NIA NIH HHS R01 AG059635
6 · The paper itself

Abstract

Cancer heterogeneity and evolution are not fully understood. Here, we show that mitochondrial DNA of the normal liver shapes tumor progression, histology, and immune environment prior to the acquisition of oncogenic mutation. Using conplastic mice, we show that mtDNA dictates the expression of the mitochondrial unfolded protein response (UPR

Indexed as

AnimalsCarcinoma, HepatocellularDNA, MitochondrialFemaleHumansLiver NeoplasmsMaleMiceMice, Inbred C57BLPregnancy-Associated Plasma Protein-ATranscriptomeUnfolded Protein ResponseDNA, MitochondrialPregnancy-Associated Plasma Protein-Acollagenconplastic miceDDR2estrogen receptorimmune exhaustedliver cancermitochondrial UPRPAPP-Asexual dimorphismUPRmt

Identifiers

PMID35045282
PMCPMC8808357
OpenAlexW4206263936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.